More-EUROPA More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making
- Coordinator
- Academisch Ziekenhuis Groningen, Netherlands
- Runs
- 1 January 2023 to 31 December 2027
- Status
- Running
- EU funding
- €7.0m
- Total cost
- €7.0m
- Partners
- 15 organisations in 7 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101095479
What the project is doing
In the project's own words, from its summary on CORDIS.
While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized. Evidence, based on RWD – real world evidence (RWE) - can contribute significantly to the evidence to support decision making throughout all phases of (clinical) drug development, as well as improve efficiency in design and conduct of clinical trial programs.
The aim of this project is to develop, implement and establish evidentiary standards and methods to address the data and evidentiary needs of regulatory authorities and HTA bodies towards a more efficient use of RWD for the development, registration and assessment of medicinal products in Europe (More-EUROPA).
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Coordinator |
| The European Multiple Sclerosis Platform Aisbl | Bruxelles / Brussel | Belgium | Participant |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| Eurordis - Rare Diseases Europe | Paris | France | Participant |
| Quinten | Paris | France | Participant |
| Quinten Health | Paris | France | Participant |
| Universite Paris Cite | Paris | France | Participant |
| Universita Cattolica Del Sacro Cuore | Milano | Italy | Participant |
| Critical Path Institute Stichting | Amsterdam | Netherlands | Participant |
| Iqvia Solutions B.v. | Amsterdam | Netherlands | Participant |
| Stichting Dutch Institute for Clinical Auditing | Leiden | Netherlands | Participant |
| Stichting Radboud Universitair Medisch Centrum | Nijmegen | Netherlands | Participant |
| Faculdade de Farmácia da Universidade de Lisboa | Lisboa | Portugal | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| Uppsala Universitet | Uppsala | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI